Similar content being viewed by others

A case-control study to evaluate the impact of the breast screening programme on mortality in England

Article23 November 2020

Roberta Maroni, Nathalie J. Massat, … Stephen W. Duffy

Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality

Article28 June 2021

Eunji Choi, Jae Kwan Jun, … Kui Son Choi

Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts

Article19 December 2018

Marta Román, Solveig Hofvind, … Xavier Castells

Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)

Article26 November 2021

Carlos Canelo-Aybar, Margarita Posso, … Pablo Alonso-Coello

The cost-effectiveness of risk-stratified breast cancer screening in the UK

Article17 October 2023

Harry Hill, Ben Kearns, … Stephen Duffy

Assessing trends of breast cancer and carcinoma in situ to monitor screening policies in developing settings

Article02 October 2019

Érika de Abreu Costa Brito, Marcela Sampaio Lima, … Rosana Cipolotti

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)

Article01 April 2023

D. Gareth Evans, Lorna McWilliams, … David P. French

The current status of risk-stratified breast screening

Article26 October 2021

Ash Kieran Clift, David Dodwell, … Julia Hippisley-Cox

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease

Article05 March 2021

Francisco Beca, Hannah Oh, … Stuart J. Schnitt